Stock screenerAll disclosures →
EDGAR →
DTIL
Conviction 75HealthcareScan · Mon, Aug 10, 2026DTIL$7.46-0.47%
ResistanceSupportVol 14Vol MA14 314.46K
May 11May 28Jun 16Jul 6Jul 23Aug 10
PRECISION BIOSCIENCES INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.precisionbiosciences.com ↗
Price7.46
Change-0.47%
Gap+0.67%
Rel volume3.19×
Avg volume340.5K
Avg $ vol2.59M
SMA 207.50
SMA 507.35
SMA 2006.05
Price vs 50+1.47%
Price vs 200+23.24%
MA stackbullish
50/200 cross—
Supertrenddown · 8.51
RSI (14)50
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D71 / 66
ADX (14)14
+DI / −DI18 / 22
RSI divergence—
MACD divergence—
ATR %+6.55%
ADR %6.31%
52w high9.28
52w low3.57
From 52w high-19.67%
Above 52w low+108.82%
New 52w highNo
SqueezeOff
Bollinger width27.03%
%B0.48
Donchian pos33.41%
Donchian high8.96
Donchian low6.70
AVWAP (52w high)8.14
vs AVWAP high-8.37%
AVWAP (52w low)6.95
vs AVWAP low+7.30%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d3.19×
Avg vol (14d)314.45K
Avg vol (20d)340.5K
Avg $ vol (20d)2.59M
Market cap—
RS 3m (vs SPY)-5.56%
RS 6m (vs SPY)+95.69%
RS line new highNo
Trend template7/8
Technical rank67.6
1 week+5.59%
1 month-14.90%
3 months-3.06%
6 months+96.18%
1 year+63.13%
YTD+81.83%
P/E-4.53
P/B4.58
P/S6.05
P/FCF-3.14
EPS-3.56
Div yield—
ROE-100.95%
ROA-36.31%
Debt/Eq0.49
Current12.82
EV/EBITDA-2.83
Gross margin—
Net margin-133.45%
Rev growth-50.12%
EPS growth-737.98%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value143.48M
Revenue0
Net income-32.65M
Gross profit—
Free cash flow-65.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out25.8M
Employees66
ListedThu, Mar 28, 2019
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank67.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance8.98
Support6.31
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DTIL
No recent disclosed trades by Congress in DTIL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DTIL · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Buehler Kevin Director · Restricted Stock Units · 2026-06-03 | Grant | 20.98K | $0 | 2026-06-03 | 2026-06-05 |
Frankel Stanley Director · Restricted Stock Units · 2026-06-03 | Grant | 20.98K | $0 | 2026-06-03 | 2026-06-05 |
Brown Melinda Director · Restricted Stock Units · 2026-06-03 | Grant | 20.98K | $0 | 2026-06-03 | 2026-06-05 |
Pire Shari Lisa Director · Restricted Stock Units · 2026-06-03 | Grant | 20.98K | $0 | 2026-06-03 | 2026-06-05 |
Germano Geno J Director · Restricted Stock Units · 2026-06-03 | Grant | 20.98K | $0 | 2026-06-03 | 2026-06-05 |
SMITH J. JEFFERSON Chief Research Officer · Restricted Stock Units · 2026-06-01 | Grant | 57.39K | $0 | 2026-06-01 | 2026-06-03 |
Amoroso Michael President and CEO · Restricted Stock Units · 2026-06-01 | Grant | 573.89K | $0 | 2026-06-01 | 2026-06-03 |
Kelly John Alexander Chief Financial Officer · Restricted Stock Units · 2026-06-01 | Grant | 193.69K | $0 | 2026-06-01 | 2026-06-03 |
Scimeca Dario General Counsel and Secretary · Restricted Stock Units · 2026-06-01 | Grant | 107.6K | $0 | 2026-06-01 | 2026-06-03 |
Pire Shari Lisa Director · Common Stock · 2026-05-20 | Exercise | 21K | — | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in DTIL · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.